A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Clinical trial NCT07153471 · RECRUITING
Trial details
- NCT number
- NCT07153471
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2028-04-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.